TestAVec sponsoring a fully funded PhD position

TestAVec is sponsoring a PhD position at Anglia Ruskin University. The Vice-Chancellor’s Studentship, match-funded by TestAVec, is currently live with a submission deadline of 8th February 2026.

This research programme focuses on developing a CAR-T model of genotoxicity using induced pluripotent stem cells (iPSCs) and TestAVec’s patented hInGeTox™ suite of assays. The successful candidate will develop key cell-culture skills, including differentiation and characterisation of T cells, generation of CAR lentiviral vectors and CAR-T cells, and functional characterisation of these cells. The hInGeTox™ model will then be used to investigate CAR-T-related genotoxicity.

The scholar will work closely with TestAVec to develop an understanding of research commercialisation, a vital skill in the cell and gene therapy space.

The programme will be based at Anglia Ruskin University's Cambridge campus, and will be primarily supervised by Principal Scientific Officer Dr Saqlain Suleman, alongside CSO Professor Michael Themis. The project is fully funded for UK home students, including tuition fees, bench fees, and a stipend.

Further details are available via the FindAPhD listing below. For informal enquiries, please contact Dr Suleman at Saqlain.suleman@aru.ac.uk.

https://www.findaphd.com/phds/project/development-of-in-vitro-genotoxicity-model-for-lentiviral-vectors-using-induced-pluripotent-stem-cell-derived-chimeric-antigen-receptor-t-cells/?p193141